Who
Patrick Plewman
SVP for Diagnostic Services
Company insider
Files Form 4 as: SVP for Diagnostic Services, Quest Diagnostics; President and CEO, Vaxgen.
In numbers
- Trades disclosed
- 78
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $6.6M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 28 Jul 2010
- Last trade
- 22 Jul 2026
- Last filed
- 27 Jul 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jul 2026filed 27 Jul 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code L | $9,51346 at $206.81 | filing |
| 22 Jul 2026filed 27 Jul 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code L | $9,51346 at $206.81 | filing |
| 20 Apr 2026filed 24 Apr 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code L | $9,54049 at $194.70 | filing |
| 20 Apr 2026filed 24 Apr 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code L | $9,54049 at $194.70 | filing |
| 5 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $589K2,855 at $206.21 | filing |
| 5 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $589K2,855 at $206.21 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $1.2M5,682 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $579K2,827 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | $1.2M5,682 at $204.86 | filing |
| 4 Mar 2026filed 6 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $579K2,827 at $204.86 | filing |
| 3 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $85K410 at $207.73 | filing |
| 3 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $85K410 at $207.73 | filing |
| 2 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $47K230 at $204.86 | filing |
| 2 Mar 2026filed 4 Mar 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $47K230 at $204.86 | filing |
| 19 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $196K958 at $204.83 | filing |
| 19 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $196K958 at $204.83 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —1,952 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $51K244 at $210.01 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest DiagnosticsDiagnostics & Labs | SEC FORM 4 Code F | $61K293 at $206.99 | filing |
| 18 Feb 2026filed 20 Feb 2026 | DGX Quest Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —9,009 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.